Citigroup
HIMS icon

Citigroup’s Hims & Hers Health HIMS Stock Holding History

Citigroup’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71M Sell
222,301
-440,627
-66% -$11.8M ﹤0.01% 1793
2026
Q1 		$13.8M Buy
662,928
+251,115
+61% +$5.93M 0.01% 1279
2025
Q4 		$13.4M Buy
411,813
+140,120
+52% +$6M 0.01% 1342
2025
Q3 		$15.4M Buy
271,693
+42,852
+19% +$2.2M 0.01% 1229
2025
Q2 		$11.4M Sell
228,841
-4,754
-2% -$215K 0.01% 1292
2025
Q1 		$6.9M Sell
233,595
-63,071
-21% -$2.34M ﹤0.01% 1640
2024
Q4 		$7.17M Buy
296,666
+141,138
+91% +$3.5M ﹤0.01% 1640
2024
Q3 		$2.86M Buy
155,528
+106,845
+219% +$1.91M ﹤0.01% 2351
2024
Q2 		$983K Sell
48,683
-12,797
-21% -$213K ﹤0.01% 2932
2024
Q1 		$951K Buy
61,480
+43,710
+246% +$493K ﹤0.01% 3071
2023
Q4 		$158K Buy
17,770
+17,009
+2,235% +$126K ﹤0.01% 4023
2023
Q3 		$4.79K Sell
761
-52,681
-99% -$392K ﹤0.01% 4730
2023
Q2 		$502K Buy
53,442
+37,273
+231% +$370K ﹤0.01% 3364
2023
Q1 		$160K Buy
16,169
+4,980
+45% +$43.6K ﹤0.01% 3845
2022
Q4 		$71.7K Sell
11,189
-1,653
-13% -$9.41K ﹤0.01% 4159
2022
Q3 		$72K Sell
12,842
-24,683
-66% -$149K ﹤0.01% 4234
2022
Q2 		$170K Buy
37,525
+2,807
+8% +$12K ﹤0.01% 3938
2022
Q1 		$185K Buy
34,718
+24,796
+250% +$123K ﹤0.01% 4117
2021
Q4 		$65K Sell
9,922
-15,632
-61% -$113K ﹤0.01% 4946
2021
Q3 		$193K Buy
25,554
+20,538
+409% +$174K ﹤0.01% 4130
2021
Q2 		$55K Sell
5,016
-9,912
-66% -$118K ﹤0.01% 4771
2021
Q1 		$197K Buy
+14,928
New +$250K ﹤0.01% 4020

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citigroup's HIMS Position: Q2 2026 in Review

Citigroup reduced its Hims & Hers Health (HIMS) stake by 66% in Q2 2026, selling an estimated $11.8M and leaving 222,301 shares worth $7.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Citigroup first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $15.4M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Citigroup held 222,301 shares of Hims & Hers Health worth $7.71M as of Q2 2026.
  • Citigroup sold 440,627 Hims & Hers Health shares in Q2 2026, an estimated $11.8M.
  • Hims & Hers Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1793 holding.
  • Citigroup first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Hims & Hers Health position peaked at $15.4M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.